Abstract
AbstractPrimary central nervous system lymphoma is a kind of extranodal lymphoma with high degree of malignancy, hidden onset and strong invasion. It is a special type of non-Hodgkin’s lymphoma and very rare in clinic. Due to little understanding of the pathogenesis and high risk factors of the disease, there are great differences in the prevention, staging and treatment plan of the disease, and there is no strict standard. In this review, we aim to comprehensively summarize the clinical characteristics of PCNSL and the promising clinical treatment strategies for PCNSL to date.
Funder
Innovative Research Group Project of the National Natural Science Foundation of China
Natural Science Foundation of Heilongjiang Province
Publisher
Springer Science and Business Media LLC
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献